202 related articles for article (PubMed ID: 14564333)
1. Platelet activation after stenting with heparin-coated versus noncoated stents.
Gurbel PA; Bliden KP
Am Heart J; 2003 Oct; 146(4):E10. PubMed ID: 14564333
[TBL] [Abstract][Full Text] [Related]
2. The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapy.
Gurbel PA; Bliden KP
Thromb Res; 2003; 112(1-2):9-12. PubMed ID: 15013266
[TBL] [Abstract][Full Text] [Related]
3. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Barrera-Ramirez C; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
Thromb Res; 2005; 115(1-2):101-8. PubMed ID: 15567460
[TBL] [Abstract][Full Text] [Related]
4. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting.
Neumann FJ; Gawaz M; Ott I; May A; Mössmer G; Schömig A
J Am Coll Cardiol; 1996 Jan; 27(1):15-21. PubMed ID: 8522689
[TBL] [Abstract][Full Text] [Related]
6. Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosis.
Gurbel PA; Samara WM; Bliden KP
Platelets; 2004 Mar; 15(2):95-9. PubMed ID: 15154601
[TBL] [Abstract][Full Text] [Related]
7. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.
Gurbel PA; Bliden KP; Hiatt BL; O'Connor CM
Circulation; 2003 Jun; 107(23):2908-13. PubMed ID: 12796140
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
[TBL] [Abstract][Full Text] [Related]
9. Uniform platelet activation exists before coronary stent implantation despite aspirin therapy.
Serebruany VL; Cummings CC; Malinin AI; Steinhubl SR; Gurbel PA
Am Heart J; 2001 Oct; 142(4):611-6. PubMed ID: 11579350
[TBL] [Abstract][Full Text] [Related]
10. Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Hernández-Antolín R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Macaya C
J Invasive Cardiol; 2004 Jun; 16(6):325-9. PubMed ID: 15156004
[TBL] [Abstract][Full Text] [Related]
11. Could stent design affect platelet activation? Results of the Platelet Activation in STenting (PAST) Study.
Gurbel PA; Callahan KP; Malinin AI; Serebruany VL; Gillis J
J Invasive Cardiol; 2002 Oct; 14(10):584-9. PubMed ID: 12368510
[TBL] [Abstract][Full Text] [Related]
12. Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy).
Serebruany VL; Malinin AI; O'connor CM; Gurbel PA;
Am Heart J; 2003 Jul; 146(1):91-8. PubMed ID: 12851613
[TBL] [Abstract][Full Text] [Related]
13. [Platelets and platelet microparticles glycoprotein IIb/IIIa complex in patients with unstable angina].
Dymicka-Piekarska V; Kemona H; Butkiewicz A; Bychowski J
Pol Merkur Lekarski; 2005 Jan; 18(103):9-12. PubMed ID: 15859538
[TBL] [Abstract][Full Text] [Related]
14. Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise.
Aurigemma C; Fattorossi A; Sestito A; Sgueglia GA; Farnetti S; Buzzonetti A; Infusino F; Landolfi R; Scambia G; Crea F; Lanza GA
Thromb Res; 2007; 120(6):901-9. PubMed ID: 17337041
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of platelet-leukocyte aggregates and platelet activation in blood: heparin-coated coiled wire stent implantation versus balloon angioplasty in acute myocardial infarction.
Jaster M; Schwimmbeck P; Spencker S; Schultheiss HP; Rauch U
Thromb Res; 2003; 112(5-6):285-9. PubMed ID: 15041271
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting.
Antonino MJ; Mahla E; Bliden KP; Tantry US; Gurbel PA
Am J Cardiol; 2009 Jun; 103(11):1546-50. PubMed ID: 19463513
[TBL] [Abstract][Full Text] [Related]
17. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry.
Gupta V; Aravamuthan BR; Baskerville S; Smith SK; Gupta V; Lauer MA; Fischell TA
J Invasive Cardiol; 2004 Jun; 16(6):304-10. PubMed ID: 15155999
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications.
Haas S; Walenga JM; Jeske WP; Fareed J
Semin Thromb Hemost; 1999; 25 Suppl 1():67-75. PubMed ID: 10357155
[TBL] [Abstract][Full Text] [Related]
19. Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia.
Straub A; Schiebold D; Wendel HP; Azevedo R; Dietz K; Ziemer G
Thromb Res; 2008; 122(3):383-9. PubMed ID: 18304613
[TBL] [Abstract][Full Text] [Related]
20. Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease.
Braun OO; Johnell M; Varenhorst C; James S; Brandt JT; Jakubowski JA; Winters KJ; Wallentin L; Erlinge D; Siegbahn A
Thromb Haemost; 2008 Oct; 100(4):626-33. PubMed ID: 18841285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
